Dcf Advisers, LLC Xencor Inc Transaction History

Dcf Advisers, LLC

$242 Million
Q3 2024

A detailed history of Dcf Advisers, LLC transactions in Xencor Inc stock. As of the latest transaction made, Dcf Advisers, LLC holds 209,479 shares of XNCR stock, worth $4.28 Million. This represents 1.74% of its overall portfolio holdings.

Number of Shares

209,479

Previous 208,979 0.24%

Holding current value

$4.28 Million

Previous $3.96 Million 6.5%

% of portfolio

1.74%

Previous 2.14%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$15.7 - $21.65 $7,850 - $10,825	500 Added 0.24%	209,479 $4.21 Million
Q1 2024 May 15, 2024	SELL	$18.65 - $26.52 $524,587 - $745,954	-28,128 Reduced 11.86%	208,979 $4.62 Million
Q4 2023 Feb 13, 2024	SELL	$16.53 - $21.42 $151,960 - $196,914	-9,193 Reduced 3.73%	237,107 $5.03 Million
Q3 2023 Nov 13, 2023	BUY	$20.08 - $25.39 $628,504 - $794,707	31,300 Added 14.56%	246,300 $4.96 Million
Q2 2023 Aug 09, 2023	BUY	$24.77 - $29.9 $123,850 - $149,500	5,000 Added 2.38%	215,000 $5.37 Million
Q1 2023 May 15, 2023	BUY	$25.95 - $36.95 $104,500 - $148,797	4,027 Added 1.96%	210,000 $5.86 Million
Q4 2022 Feb 13, 2023	SELL	$24.79 - $30.86 $640,251 - $797,021	-25,827 Reduced 11.14%	205,973 $5.36 Million
Q3 2022 Nov 14, 2022	SELL	$24.62 - $32.44 $443,160 - $583,920	-18,000 Reduced 7.21%	231,800 $6.02 Million
Q2 2022 Aug 11, 2022	SELL	$19.74 - $29.01 $142,128 - $208,872	-7,200 Reduced 2.8%	249,800 $6.84 Million
Q1 2022 May 13, 2022	BUY	$26.68 - $41.63 $406,523 - $634,316	15,237 Added 6.3%	257,000 $6.86 Million
Q4 2021 Feb 10, 2022	BUY	$33.67 - $43.44 $396,060 - $510,984	11,763 Added 5.11%	241,763 $9.7 Million
Q3 2021 Nov 15, 2021	BUY	$30.65 - $35.68 $1.01 Million - $1.18 Million	33,000 Added 16.75%	230,000 $7.51 Million
Q2 2021 Aug 13, 2021	BUY	$34.33 - $44.68 $240,310 - $312,760	7,000 Added 3.68%	197,000 $6.8 Million
Q1 2021 May 12, 2021	SELL	$40.81 - $53.88 $397,897 - $525,330	-9,750 Reduced 4.88%	190,000 $8.18 Million
Q4 2020 Feb 12, 2021	BUY	$36.63 - $47.63 $412,087 - $535,837	11,250 Added 5.97%	199,750 $8.72 Million
Q3 2020 Nov 13, 2020	SELL	$30.09 - $43.02 $56,178 - $80,318	-1,867 Reduced 0.98%	188,500 $7.31 Million
Q2 2020 Aug 13, 2020	BUY	$27.76 - $33.42 $2.95 Million - $3.55 Million	106,367 Added 126.63%	190,367 $6.17 Million
Q1 2020 May 12, 2020	BUY	$20.69 - $37.79 $570,526 - $1.04 Million	27,575 Added 48.87%	84,000 $2.51 Million
Q4 2019 Feb 12, 2020	BUY	$32.75 - $41.43 $1.85 Million - $2.34 Million	56,425 New	56,425 $1.94 Million

Others Institutions Holding XNCR

# of Institutions

215

Shares Held

71.5M

Call Options Held

2.5K

Put Options Held

7.9K

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.22B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dcf Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dcf Advisers, LLC with notifications on news.

Account